Electrochemical immunosensor for simultaneous determination of interleukin-1 beta and tumor necrosis factor alpha in serum and saliva using dual screen printed electrodes modified with functionalized double–walled carbon nanotubes

Analytica Chimica Acta

Volumn 959, Issue , 2017, Pages 66-73

  Sanchez Tirado E ^a   Salvo, C ^a   Gonzalez Cortes A ^a   Yanez Sedeno P ^a   Langa, F ^b   Pingarron J M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

Double walled carbon nanotubes; Electrochemical immunosensor; Interleukin 1 beta; Multiplex; Saliva; Tumor necrosis factor alpha

Indexed keywords

BODY FLUIDS; CARBON NANOTUBES; ELECTROCHEMICAL ELECTRODES; ELECTRODES; GLYCOPROTEINS; IMMUNOSENSORS; MACROPHAGES; MULTIPLEXING; NANOTUBES; PROTEINS; TUMORS; YARN;

DOUBLE WALLED CARBON NANOTUBES; ELECTROCHEMICAL IMMUNOSENSORS; INTERLEUKIN-1; SALIVA; TUMOR NECROSIS FACTOR ALPHA;

MULTIWALLED CARBON NANOTUBES (MWCN);

DOUBLE WALLED NANOTUBE; HORSERADISH PEROXIDASE; HYDROGEN PEROXIDE; HYDROQUINONE; INTERLEUKIN 1BETA; STREPTAVIDIN; TUMOR NECROSIS FACTOR; CARBON NANOTUBE; IL1B PROTEIN, HUMAN;

ARTICLE; BLOOD ANALYSIS; DUAL SCREEN PRINTED CARBON ELECTRODE; ELECTROCHEMICAL DETECTION; ELECTRODE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOSENSOR; LIMIT OF DETECTION; REPRODUCIBILITY; SALIVA ANALYSIS; STORAGE; BLOOD; CHEMISTRY; ELECTROCHEMICAL ANALYSIS; GENETIC PROCEDURES; IMMUNOASSAY; SALIVA;

BIOSENSING TECHNIQUES; ELECTROCHEMICAL TECHNIQUES; ELECTRODES; HUMANS; HYDROGEN PEROXIDE; IMMUNOASSAY; INTERLEUKIN-1BETA; NANOTUBES, CARBON; REPRODUCIBILITY OF RESULTS; SALIVA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85008425442     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2016.12.034     Document Type: Article

References (38)

1. [1] Liu, G., Qi, M., Hutchinson, M.R., G.Yang, E.M. Goldys, Recent advances in cytokine detection by immunosensing. Biosens. Bioelectron. 79 (2016), 810–821.
2. [2] Whicher, J., Evans, S., Cytokines in disease. Clin. Chem. 36 (1990), 1269–1281.
3. [3] Baraket, A., Lee, M., Zine, N., Trivella, M.G., Zabala, M., Bausells, J., Sigaud, M., Jaffrezic-Renault, N., Errachid, A., A fully integrated electrochemical bioMEMS fabrication process for cytokine detection: application for heart failure. Proc. Eng. 87 (2014), 377–379.
4. [4] Shaftel, S.S., Griffin, W.S.T., ÓBanion, M.K., The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J. Neuroinflam., 5, 2008, 7.
5. [5] Feldmann, M., Brennan, F.M., Maini, R.N., Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14 (1996), 397–440.
6. [6] Palladino, M.A., Bahjat, F.R., Theodorakis, E.A., Moldawer, L.L., Anti-TNF-[alpha] therapies: the next generation. Nat. Rev. Drug Discov. 2 (2003), 736–746.
7. [7] Last-Barney, K., Homon, C.A., Faanes, R.B., Merluzzi, V.J., Synergistic and overlap-ping activities of tumor necrosis factor alpha and IL-1. J. Immunol. 141 (1988), 527–530.
8. [8] Musto, P., Matera, R., Minervini, M.M., Checchia-de Ambrosio, C., Bodenizza, C., Falcone, A., Carotenuto, M., Low serum levels of tumor necrosis factor and interleukin-1 beta in myelodysplastic syndromes responsive to recombinant erythropoietin. Haematologica 79 (1994), 265–268.
9. [9] Demircan, N., Safran, B.G., Soylu, M., Ozcan, M.M., Sizmaz, S., Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye 20 (2006), 1366–1369.
10. [10] Di Battista, A.P., Rhind, S.G., Hutchison, M.G., Hassan, S., Shiu, M.Y., Inaba, K., Topolovec-Vranic, J., Neto, A.C., Rizoli, S.B., Baker, A.J., Inflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injury. J. Neuroinflamm., 13, 2016, 40.
11. [11] Krause, C.E., Otieno, B.A., Bishop, G.W., Phadke, G., Choquette, L., Lalla, R.V., Peterson, D.E., Rusling, J.F., Ultrasensitive microfluidic array for serum pro-inflammatory cytokines and C-reactive protein to assess oral mucositis risk in cancer patients. Anal. Bioanal. Chem. 407 (2015), 7239–7243.
12. [12] Brailo, V., Vucicevic-Boras, V., Lukac, J., Biocina-Lukenda, D., Zilic-Alajbeg, I., Milenovic, A., Balija, M., Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer. Med. Oral Patol. Oral Cir. Bucal 17 (2012), 10–15.
13. [13] Fernandes Gomes, F.I., Brito Aragão, M.G., Barroso Barbosa, F.C., Marques Bezerra, M., Teixeira Pinto, V.de P., Vasconcelos Chaves, H., Inflammatory cytokines Interleukin-1β and tumour necrosis factor-α - novel biomarkers for the detection of periodontal diseases: a literature review. J. Oral Maxillofac. Res., 7, 2016, e2.
14. [14] Yuan, L., Hua, X., Wu, Y., Pan, X., Liu, S., Polymer-functionalized silica nanosphere labels for ultrasensitive detection of tumor necrosis factor-alpha. Anal. Chem. 83:83 (2011), 6800–6809.
15. [15] Yin, Z., Liu, Y., Jiang, L.-P., Zhu, J.-J., Electrochemical immunosensor of tumor necrosis factor alpha based on alkaline phosphatase functionalized nanospheres. Biosens. Bioelectron. 26 (2011), 1890–1894.
16. [16] Li, T., Si, Z., Hu, L., Qia, H., Yang, M., Prussian Blue-functionalized ceria nanoparticles as label for ultrasensitive detection of tumor necrosis factor alpha. Sens. Actuators B 171– 172 (2012), 1060–1065.
17. [17] Hou, Y., Li, T., Huang, H., Quan, H., Miao, X., Yang, M., Electrochemical immunosensor for the detection of tumor necrosis factor alpha based on hydrogel prepared from ferrocene modified amino acid. Sens. Actuators B 182 (2013), 605–609.
18. [18] Sun, Z., Deng, L., Gan, H., Shen, R., Yang, M., Zhang, Y., Sensitive immunosensor for tumor necrosis factor alpha based on dual signal amplification of ferrocene modified self-assembled peptide nanowire and glucose oxidase functionalized gold nanorod. Biosens. Bioelectron. 39 (2013), 215–219.
19. [19] Mazloum-Ardakani, M., Hosseinzadeh, L., Taleat, Z., Two kinds of electrochemical immunoassays for the tumor necrosis factor α in human serum using screen-printed graphite electrodes modified with poly(anthranilic acid). Microchim. Acta 181 (2014), 917–924.
20. [20] La Belle, J.T., Demirok, U.K., Patelc, D.R., Cook, C.B., Development of a novel single sensor multiplexed marker assay. Analyst 136 (2011), 1496–1501.
21. [21] Bettazzi, F., Enayati, L., Campos Sánchez, I., Motaghed, R., Mascini, M., Palchetti, I., Electrochemical bioassay for the detection of TNF-a using magnetic beads and disposable screen-printed array of electrodes. Bioanalysis 5 (2013), 11–19.
22. [22] Yuan, L., Wei, W., Liu, S.Q., Label-free electrochemical immunosensors based on surface-initiated atom radical polymerization. Biosens. Bioelectron. 38 (2012), 79–85.
23. 6] as signal for facile and sensitive determination of tumor necrosis factor-alpha. Sens. Actuators B 184 (2013), 1–7.
24. [24] Pui, T.S., Kongsuphol, P., Arya, S.K., Bansal, T., Detection of tumor necrosis factor (TNF-alpha) in cell culture medium with label free electrochemical impedance spectroscopy. Sens. Actuators B 181 (2013), 494–500.
25. [25] Eletxigerra, U., Martínez-Perdiguero, J., Merino, S., Villalonga, R., Pingarrón, J.M., Campuzano, S., Amperometric magnetoimmunoassay for the direct detection of tumor necrosis factor alpha biomarker in human serum. Anal. Chim. Acta 838 (2014), 37–44.
26. [26] Kongsuphol, P., Ng, H.H., Pursey, J.P., Arya, S.K., Wong, C.C., Stulz, E., Park, M.K., EIS-based biosensor for ultra-sensitive detection of TNF-α from non-diluted human serum. Biosens. Bioelectron. 61 (2014), 274–279.
27. [27] Mazloum-Ardakani, M., Hosseinzadeh, L., Highly-sensitive label-free immunosensor for tumor necrosis factor a based on Ag@Pt core–shell nanoparticles supported on MW CNTs as an efficient electrocatalyst nanocomposite. RSC Adv. 5 (2015), 70781–70786.
28. [28] Mazloum-Ardakani, M., Hosseinzadeh, L., Khoshroo, A., Label-free electrochemical immunosensor for detection of tumor necrosis factor α based on fullerene-functionalized carbon nanotubes/ionic liquid. J. Electroanal. Chem. 757 (2015), 58–64.
29. [29] Eletxigerra, U., Martinez-Perdiguero, J., Merino, S., Disposable microfluidic immuno-biochip for rapid electrochemical detection of tumor necrosis factor alpha biomarker. Sens. Actuators B 221 (2015), 1406–1411.
30. [30] Baydemir, G., Bettazzi, F., Palchetti, I., Voccia, D., Strategies for the development of an electrochemical bioassay for TNF- alpha detection by using a non-immunoglobulin bioreceptor. Talanta 151 (2016), 141–147.
31. [31] Green, A.A., Hersam, M.C., Properties and application of double-walled carbon nanotubes sorted by outer-wall electronic type. ACS Nano 5 (2011), 1459–1467.
32. [32] Pumera, M., Electrochemical properties of double wall carbon nanotube electrodes. Nanoscale Res. Lett. 2 (2007), 87–93.
33. [33] Moore, E., Flavel, B.S., Ellis, A.V., Shapter, J.G., Comparison of double-walled with single-walled carbon nanotube electrodes by electrochemistry. Carbon 49 (2011), 2639–2647.
34. [34] Ooi, H.W., Cooper, S.J., Huang, C.-Y., Jennins, D., Chung, E., Maeji, N.J., Whittaker, A.K., Coordination complexes as molecular glue for immobilization of antibodies on cyclic olefin copolymer surfaces. Anal. Biochem. 456 (2014), 6–13.
35. [35] Eguílaz, M., Moreno-Guzmán, M., Campuzano, S., González-Cortés, A., Yáñez-Sedeño, P., Pingarrón, J.M., An electrochemical immunosensor for testosterone using functionalized magnetic beads and screen-printed carbon electrodes. Biosens. Bioelectron. 26 (2010), 517–522.
36. [36] Ojeda, I., Moreno-Guzmán, M., González-Cortés, A., Yáñez-Sedeño, P., Pingarrón, J.M., Electrochemical magnetoimmunosensor for the ultrasensitive determination of interleukin-6 in saliva and urine using poly-HRP streptavidin conjugates as labels for signal amplification. Anal. Bioanal. Chem. 406 (2014), 6363–6371.
37. [37] Dogan, Y., Akarsu, S., Ustundag, B., Yilmaz, E., Gurgoze, M.K., Serum IL-1β, IL-2 and IL-6 in insulin-dependent diabetic children. Mediat. Inflamm., 2006, 1–6.
38. [38] Arica, O., Aral, M., Sasmaz, S., Ciragil, P., Serum levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17 and IL-18 in patients with active psoriasis and correlation with disease severity. Mediat. Inflamm., 2005, 273–279.